Showing 3011-3020 of 9587 results for "".
The Importance and Utility of GEP Testing
https://practicaldermatology.com/series/updates-in-skin-cancer/the-importance-and-utility-of-gep-testing/35597/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses gene expression profiling technology and its importance in the diagnosis and prognostication of melanomas.Skin Coverage as a Medical Benefit
https://practicaldermatology.com/series/c-suite-chats/skin-coverage-as-a-medical-benefit/35559/Mike Jafar, Founder and CEO of Joya Health, talks about the importance of having skin coverage as a medical benefit, trends in dermatology, and the driver behind the rising rates of melanoma.'Combination Is Back,' Doctor Declares at Maui Derm
https://reachmd.com/programs/practical-dermatology/combination-is-back-doctor-declares-at-maui-derm/32918/One of the most important studies of the past few years for dermatologists involved patients with ulcerative colitis, according to Arthur Kavanaugh, MD.Drs. Rosen and Bhatia Highlight Latest Drugs at Maui Derm
https://reachmd.com/programs/practical-dermatology/drs-rosen-and-bhatia-highlight-latest-drugs-at-maui-derm/32914/The current landscape of therapeutics for dermatologic conditions is dramatic, with new groundbreaking drugs continuously becoming available.Neuromodulators and Dermal Fillers: Dr. Gold
https://reachmd.com/programs/practical-dermatology/neuromodulators-and-dermal-fillers-dr-gold/32694/Michael Gold, MD, talks about the new neurotoxins and applications, as well as fillers, that he covered during "Neuromodulators and Dermal Fillers: What's New, What's Coming and What Are We Doing That's New in 2025" at Maui Derm 2025."You've Just Been Served": Dr. Goldberg
https://reachmd.com/programs/practical-dermatology/youve-just-been-served-dr-goldberg/32691/David Goldberg, MD, JD, discusses lessening the likelihood of lawsuits and winning lawsuits involving negligence, employees, and teledermatology, which he covered during his session, "You've Just Been Served," at Maui Derm 2025.Improving Treatment Capabilities for Vitiligo
https://practicaldermatology.com/series/c-suite-chats/improving-treatment-capabilities-for-vitiligo/29745/David Domzalski, CEO and President of Vyne Therapeutics, discusses what makes vitiligo difficult to treat and how his company is working to address those challenges.What's New in Topical Treatment for Plaque Psoriasis?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-in-topical-treatment-for-plaque-psoriasis/20235/Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, discusses what’s new in topical treatment of plaque psoriasis and the importance of an “elegant vehicle” for patients to use in their care regimens.Dermatology Innovations
https://practicaldermatology.com/topics/psoriasis/dermatology-innovations/20044/From topical therapies to JAK inhibitors, there are many new drugs available to treat a wide variety of dermatologic conditions. Neal Bhatia, MD reviews what's new for atopic dermatitis, alopecia areata, scabies, lice, onychomycosis, and more. Plus, he discusses the importance of new delivery systemDermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for t